1. Home
  2. INLX vs FEMY Comparison

INLX vs FEMY Comparison

Compare INLX & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellinetics Inc.

INLX

Intellinetics Inc.

N/A

Current Price

$5.35

Market Cap

25.5M

Sector

Technology

ML Signal

N/A

FEMY

Femasys Inc.

N/A

Current Price

$2.55

Market Cap

22.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INLX
FEMY
Founded
1996
2004
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.5M
22.4M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
INLX
FEMY
Price
$5.35
$2.55
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.50
AVG Volume (30 Days)
4.6K
1.6M
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
44.71
EPS
N/A
N/A
Revenue
$11,336.00
$2,293,313.00
Revenue This Year
$16.86
$105.16
Revenue Next Year
N/A
$200.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40.77
52 Week Low
$5.00
$0.29
52 Week High
$12.38
$6.29

Technical Indicators

Market Signals
Indicator
INLX
FEMY
Relative Strength Index (RSI) 44.94 43.03
Support Level $5.11 $0.41
Resistance Level $5.83 $3.33
Average True Range (ATR) 0.27 0.28
MACD 0.02 -0.04
Stochastic Oscillator 23.38 9.57

Price Performance

Historical Comparison
INLX
FEMY

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Software and Document Services. The Software segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Services offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Services Segment.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: